In­side the race to make psy­che­delics 'main­stream med­i­ci­nes'

When Berra Yazar-Klosin­s­ki was wrap­ping up her PhD in mol­e­c­u­lar cell and de­vel­op­men­tal bi­ol­o­gy at UC San­ta Cruz, there was an unas­sum­ing lit­tle of­fice right down the road, hid­den in­side a bun­ga­low-style house with a postage-square lawn.

Tucked away on a busy street, the build­ing didn’t strike Yazar-Klosin­s­ki as the type of place where sci­en­tif­ic re­search would oc­cur. But in­side, she would learn, was the Mul­ti­dis­ci­pli­nary As­so­ci­a­tion for Psy­che­del­ic Stud­ies (MAPS), a non­prof­it work­ing on turn­ing psy­che­delics in­to med­i­cines for a host of men­tal ill­ness­es.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER